A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
A 16ft python that would have been "capable of attacking a person" has been found dead in a canal sparking a police investigation.
Icy on Tuesday night, early wintry showers turning increasingly to rain at lower levels. Pressure building midweek, temperatures rising
A man whose wife and son died at Furness General Hospital says he has never received an apology for failings which led to their deaths.